Susquehanna International Group, LLP Arcturus Therapeutics Holdings Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$18.08 - $25.38 $511,663 - $718,254	28,300 Added 50.72%	84,100 $1.95 Million
Q2 2024 Aug 15, 2024	SELL	$24.35 - $44.39 $2.3 Million - $4.19 Million	-94,400 Reduced 62.85%	55,800 $1.36 Million
Q1 2024 May 07, 2024	BUY	$31.23 - $42.99 $2.83 Million - $3.89 Million	90,500 Added 151.59%	150,200 $5.07 Million
Q4 2023 Feb 14, 2024	SELL	$17.71 - $32.97 $102,718 - $191,226	-5,800 Reduced 8.85%	59,700 $1.88 Million
Q3 2023 Nov 14, 2023	SELL	$25.44 - $37.35 $936,192 - $1.37 Million	-36,800 Reduced 35.97%	65,500 $1.67 Million
Q2 2023 Aug 11, 2023	BUY	$23.94 - $32.36 $7,182 - $9,708	300 Added 0.29%	102,300 $2.93 Million
Q1 2023 May 16, 2023	SELL	$14.72 - $23.97 $285,568 - $465,018	-19,400 Reduced 15.98%	102,000 $2.44 Million
Q4 2022 Feb 14, 2023	SELL	$14.14 - $23.06 $350,672 - $571,888	-24,800 Reduced 16.96%	121,400 $2.06 Million
Q3 2022 Nov 14, 2022	BUY	$13.05 - $22.13 $63,945 - $108,437	4,900 Added 3.47%	146,200 $2.17 Million
Q2 2022 Aug 15, 2022	SELL	$12.26 - $31.17 $1.5 Million - $3.81 Million	-122,300 Reduced 46.4%	141,300 $2.22 Million
Q1 2022 May 16, 2022	BUY	$17.64 - $39.57 $1.98 Million - $4.44 Million	112,100 Added 73.99%	263,600 $7.11 Million
Q4 2021 Feb 14, 2022	SELL	$34.2 - $47.56 $1.55 Million - $2.15 Million	-45,300 Reduced 23.02%	151,500 $5.61 Million
Q3 2021 Nov 15, 2021	BUY	$27.88 - $58.25 $2.15 Million - $4.5 Million	77,200 Added 64.55%	196,800 $9.4 Million
Q2 2021 Aug 11, 2021	SELL	$25.79 - $42.11 $7.51 Million - $12.3 Million	-291,300 Reduced 70.89%	119,600 $4.05 Million
Q1 2021 May 17, 2021	SELL	$38.75 - $86.92 $77,500 - $173,840	-2,000 Reduced 0.48%	410,900 $17 Million
Q4 2020 Feb 16, 2021	BUY	$34.61 - $123.66 $9.67 Million - $34.6 Million	279,400 Added 209.29%	412,900 $17.9 Million
Q3 2020 Nov 16, 2020	BUY	$37.49 - $63.19 $618,585 - $1.04 Million	16,500 Added 14.1%	133,500 $5.73 Million
Q2 2020 Aug 14, 2020	BUY	$12.66 - $58.27 $829,230 - $3.82 Million	65,500 Added 127.18%	117,000 $5.47 Million
Q1 2020 May 15, 2020	BUY	$9.31 - $18.26 $282,093 - $553,278	30,300 Added 142.92%	51,500 $700,000
Q4 2019 Feb 14, 2020	SELL	$8.93 - $12.41 $85,728 - $119,136	-9,600 Reduced 31.17%	21,200 $230,000
Q3 2019 Nov 14, 2019	SELL	$8.8 - $14.5 $79,200 - $130,500	-9,000 Reduced 22.61%	30,800 $316,000
Q2 2019 Nov 14, 2019	BUY	$5.78 - $9.79 $230,044 - $389,641	39,800 New	39,800 $376,000

Others Institutions Holding ARCT

# of Institutions

180

Shares Held

25.7M

Call Options Held

195K

Put Options Held

133K

Federated Hermes, Inc. Pittsburgh, PA

4.69M
Shares

$75.2 Million
0.25% of portfolio
Black Rock Inc. New York, NY

2.65M
Shares

$42.5 Million
0.0% of portfolio
Nikko Asset Management Americas, Inc.

2.32M
Shares

$37.1 Million
0.62% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.28M
Shares

$36.5 Million
0.04% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

2.1M
Shares

$33.7 Million
0.46% of portfolio

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $426M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account